(DBX1) Xtrackers - MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0292107645
DBX1: ETF, Emerging Markets, Swap, UCITS, Index
The Xtrackers - MSCI Emerging Markets Swap UCITS ETF (XETRA:DBX1) is a swap-based exchange-traded fund designed to provide exposure to emerging markets equities. It is managed by DWS, a leading global investment manager, and is listed on the XETRA exchange in Germany. The fund tracks the Morningstar EM TME NR USD index, which offers a broad representation of emerging market equities. DBX1 is structured as a UCITS-compliant ETF, ensuring adherence to European regulatory standards for investor protection and transparency.
From a technical standpoint, DBX1 exhibits moderate trading activity, with an average 20-day volume of 6,692 shares. The ETF is currently trading at 48.69, above its 20-day simple moving average (SMA) of 45.77 but slightly below its 50-day SMA of 48.34. The 200-day SMA stands at 48.87, indicating a relatively stable trend over the longer term. Volatility, as measured by the Average True Range (ATR), is 0.98, suggesting moderate price fluctuations.
Fundamentally, DBX1 manages assets under management (AUM) of 732.57 million EUR, reflecting its popularity among investors seeking emerging market exposure. The ETFs swap-based structure allows for efficient replication of the underlying index, typically with lower tracking error. Based on the current technical and fundamental data, DBX1 is expected to maintain its stable performance, with potential upside driven by improving emerging market fundamentals. However, risks such as geopolitical tensions and currency fluctuations remain key considerations for investors.
Additional Sources for DBX1 ETF
DBX1 ETF Overview
Market Cap in USD | 823m |
Category | Global Emerging Markets Equity |
TER | 0.49% |
IPO / Inception | 2007-06-22 |
DBX1 ETF Ratings
Growth Rating | 23.4 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -18.6 |
Analysts | - |
Fair Price Momentum | 43.58 EUR |
Fair Price DCF | - |
DBX1 Dividends
Currently no dividends paidDBX1 Growth Ratios
Growth Correlation 3m | -8.2% |
Growth Correlation 12m | 35.2% |
Growth Correlation 5y | 17.9% |
CAGR 5y | 5.19% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 0.57 |
Alpha | -3.16 |
Beta | 0.623 |
Volatility | 13.45% |
Current Volume | 2.7k |
Average Volume 20d | 1.9k |
As of June 01, 2025, the stock is trading at EUR 48.85 with a total of 2,727 shares traded.
Over the past week, the price has changed by -1.62%, over one month by +4.55%, over three months by -5.32% and over the past year by +5.09%.
Neither. Based on ValueRay´s Analyses, Xtrackers - MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 23.36 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBX1 is around 43.58 EUR . This means that DBX1 is currently overvalued and has a potential downside of -10.79%.
Xtrackers - MSCI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, DBX1 Xtrackers - MSCI Emerging will be worth about 49.4 in June 2026. The stock is currently trading at 48.85. This means that the stock has a potential upside of +1.11%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 49.4 | 1.1% |